<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 16, 2001
AMERICAN BIO MEDICA CORPORATION
--------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
------------------------------- ---------------------- ----------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
<PAGE> 2
ITEM 5. OTHER EVENTS
On January 16, 2001, American Bio Medica Corporation, A New York
corporation, announced the resignation of Stan Cipkowski as chairman of the
board of directors and chief executive officer and the appointment of Robert L.
Aromando Jr. as American Bio Medica Corporation's new chief executive officer
and chairman of the board of directors. Cipkowski to remain president and a
director of the Company. A copy of American Bio Medica Corporation's press
release announcing this appointment is attached as and incorporated by reference
herein.
2
<PAGE> 3
ITEM 7. EXHIBITS
(c) Exhibits
99.1 American Bio Medica Corporation press release dated 1-16-01
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION
(Registrant)
Dated: January 16, 2001 By: /s/ Stan Cipkowski
-------------------------------
Stan Cipkowski,
President
4
